These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24561134)

  • 1. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
    Weeke P; Mosley JD; Hanna D; Delaney JT; Shaffer C; Wells QS; Van Driest S; Karnes JH; Ingram C; Guo Y; Shyr Y; Norris K; Kannankeril PJ; Ramirez AH; Smith JD; Mardis ER; Nickerson D; George AL; Roden DM
    J Am Coll Cardiol; 2014 Apr; 63(14):1430-7. PubMed ID: 24561134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.
    Kääb S; Crawford DC; Sinner MF; Behr ER; Kannankeril PJ; Wilde AA; Bezzina CR; Schulze-Bahr E; Guicheney P; Bishopric NH; Myerburg RJ; Schott JJ; Pfeufer A; Beckmann BM; Martens E; Zhang T; Stallmeyer B; Zumhagen S; Denjoy I; Bardai A; Van Gelder IC; Jamshidi Y; Dalageorgou C; Marshall V; Jeffery S; Shakir S; Camm AJ; Steinbeck G; Perz S; Lichtner P; Meitinger T; Peters A; Wichmann HE; Ingram C; Bradford Y; Carter S; Norris K; Ritchie MD; George AL; Roden DM
    Circ Cardiovasc Genet; 2012 Feb; 5(1):91-9. PubMed ID: 22100668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes.
    Ramirez AH; Shaffer CM; Delaney JT; Sexton DP; Levy SE; Rieder MJ; Nickerson DA; George AL; Roden DM
    Pharmacogenomics J; 2013 Aug; 13(4):325-9. PubMed ID: 22584458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
    Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
    Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.
    Lopez-Medina AI; Chahal CAA; Luzum JA
    Pharmacogenomics; 2022 Jun; 23(9):543-557. PubMed ID: 35698903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study.
    Lopez-Medina AI; Campos-Staffico AM; A Chahal CA; Volkers I; Jacoby JP; Berenfeld O; Luzum JA
    Pharmacogenomics; 2024 Feb; 25(3):117-131. PubMed ID: 38506312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future.
    Crotti L; Schwartz PJ
    J Am Coll Cardiol; 2014 Apr; 63(14):1438-40. PubMed ID: 24561140
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
    Paulussen AD; Gilissen RA; Armstrong M; Doevendans PA; Verhasselt P; Smeets HJ; Schulze-Bahr E; Haverkamp W; Breithardt G; Cohen N; Aerssens J
    J Mol Med (Berl); 2004 Mar; 82(3):182-8. PubMed ID: 14760488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
    Itoh H; Sakaguchi T; Ding WG; Watanabe E; Watanabe I; Nishio Y; Makiyama T; Ohno S; Akao M; Higashi Y; Zenda N; Kubota T; Mori C; Okajima K; Haruna T; Miyamoto A; Kawamura M; Ishida K; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Sugimoto Y; Ashihara T; Hayashi H; Ito M; Imoto K; Matsuura H; Horie M
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):511-23. PubMed ID: 19843919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
    Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation.
    Simon ST; Lin M; Trinkley KE; Aleong R; Rafaels N; Crooks KR; Reiter MJ; Gignoux CR; Rosenberg MA
    PLoS One; 2024; 19(6):e0303261. PubMed ID: 38885227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.
    Schwartz PJ; Woosley RL
    J Am Coll Cardiol; 2016 Apr; 67(13):1639-1650. PubMed ID: 27150690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study.
    Lehtinen AB; Daniel KR; Shah SA; Nelson MR; Ziegler JT; Freedman BI; Carr JJ; Herrington DM; Langefeld CD; Bowden DW
    Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):72-9. PubMed ID: 19149796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic background predisposing the drug-induced long QT syndrome].
    Horie M
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):401-7. PubMed ID: 12835534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-QT caused by drugs and torsade de pointes: a genetic basis?].
    Schwartz PJ
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):277-9. PubMed ID: 12497921
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1.
    Kubota T; Shimizu W; Kamakura S; Horie M
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):1048-54. PubMed ID: 11021476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular predictors of drug-induced prolongation of the QT interval.
    Dilaveris PE
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):105-18. PubMed ID: 15853698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism.
    Lin L; Horigome H; Nishigami N; Ohno S; Horie M; Sumazaki R
    J Electrocardiol; 2012; 45(6):770-3. PubMed ID: 22999324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of acquired long QT syndrome.
    Roden DM; Viswanathan PC
    J Clin Invest; 2005 Aug; 115(8):2025-32. PubMed ID: 16075043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.